광간섭단층촬영(OCT) 시장 보고서 : 유형, 기술, 용도, 지역별(2025-2033년)

The global optical coherence tomography market size reached USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.8 Billion by 2033, exhibiting a growth rate (CAGR) of 11.59% during 2025-2033.

Optical coherence tomography (OCT) refers to a non-invasive imaging technique used to obtain high-resolution cross-sectional images of the retina. Tabletop and handheld are some of the commonly available types of OCT devices. They consist of an interferometer and short-pulse lasers with low coherence and a broad bandwidth light source. OCT is widely used in various healthcare domains, such as ophthalmology, oncology, cardiovascular, and dermatology. It is also used to detect the retinal thickness and aids in the early detection and diagnosis of retinal diseases and conditions. It also provides precise imaging of neointimal stent strut coverage in follow-up exams and assists in the easier evaluation of stent strut apposition against the vessel wall.

Optical Coherence Tomography Market Trends:

The increasing incidences of retinal and choroidal disorders and visual impairments across the globe are creating a positive outlook for the market. Optical coherence tomography is widely used by an ophthalmologist for screening and diagnosing retinal-related disorders, including tear and detachment, diabetic retinopathy, macular hole, and retinitis pigmentosa. Apart from this, various product innovations, such as the introduction of higher-performing devices that assist in enhancing accuracy and improving the overall quality of eye care, are providing an impetus to the market growth. Additionally, the increasing geriatric population and rising instances of cancer are also favoring the market growth. Optical coherence tomography aids in early cancer detection and provides information on nuclear-to-cytoplasmic ratio, nuclear size and shape, and the organization and structure of glands. Other factors, including the increasing demand for early diagnosis methods, widespread product utilization in drug delivery, and significant improvements in healthcare technologies, are anticipated to drive the market further toward growth.

Key Market Segmentation:

Breakup by Type:

• Handheld OCT Devices
• Tabletop OCT Devices
• Others

Breakup by Technology:

• Time Domain OCT (TDOCT)
• Frequency Domain OCT (FD-OCT)

Breakup by Application:

• Dermatology
• Ophthalmology
• Cardiovascular
• Oncology
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agfa-Gevaert N.V., Agiltron Inc., Carl Zeiss AG, Haag-Streit Group, Heidelberg Engineering Inc., Leica Microsystems GmbH (Danaher Corporation), Novacam Technologies Inc., OPTOPOL Technology Sp. z o.o., Terumo Corporation, Thorlabs Inc. and Topcon Corporation.

Key Questions Answered in This Report

• 1.What was the size of the global optical coherence tomography market in 2024?
• 2.What is the expected growth rate of the global optical coherence tomography market during 2025-2033?
• 3.What has been the impact of COVID-19 on the global optical coherence tomography market?
• 4.What are the key factors driving the global optical coherence tomography market?
• 5.What is the breakup of the global optical coherence tomography market based on the type?
• 6.What is the breakup of the global optical coherence tomography market based on the application?
• 7.What are the key regions in the global optical coherence tomography market?
• 8.Who are the key players/companies in the global optical coherence tomography market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Optical Coherence Tomography Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Handheld OCT Devices
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Tabletop OCT Devices
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Others
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Technology

• 7.1 Time Domain OCT (TDOCT)
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Frequency Domain OCT (FD-OCT)
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Dermatology
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ophthalmology
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Cardiovascular
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Oncology
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abbott Laboratories
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Agfa-Gevaert N.V.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Agiltron Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Carl Zeiss AG
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 SWOT Analysis
  • 14.3.5 Haag-Streit Group
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Heidelberg Engineering Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Leica Microsystems GmbH (Danaher Corporation)
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Novacam Technologies Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 OPTOPOL Technology Sp. z o.o.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Terumo Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Thorlabs Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Topcon Corporation
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis